BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1383437)

  • 1. The impact of chemotherapy on the quality of life of breast cancer patients.
    Campora E; Naso C; Vitullo MT; Giudici S; Camoirano A; Repetto L; Rosso R
    J Chemother; 1992 Feb; 4(1):59-63. PubMed ID: 1383437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health-related quality of life in early breast cancer.
    Groenvold M
    Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapy versus ovarian ablation as adjuvant therapy for breast cancer: impact on health-related quality of life in a randomized trial.
    Groenvold M; Fayers PM; Petersen MA; Mouridsen HT
    Breast Cancer Res Treat; 2006 Aug; 98(3):275-84. PubMed ID: 16541325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experiences of Patients With Breast Cancer of Participating in a Lifestyle Intervention Study While Receiving Adjuvant Chemotherapy.
    Vassbakk-Brovold K; J Antonsen A; Berntsen S; Kersten C; Fegran L
    Cancer Nurs; 2018; 41(3):218-225. PubMed ID: 28221215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in functional status and physical and psychological symptoms in women receiving chemotherapy for breast cancer.
    Ogce F; Ozkan S
    Asian Pac J Cancer Prev; 2008; 9(3):449-52. PubMed ID: 18990020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of age on Health-Related Quality of Life (HRQoL) and symptoms among postmenopausal women with breast cancer receiving adjuvant chemotherapy.
    Browall MM; Ahlberg KM; Persson LO; Karlsson PO; Danielson EB
    Acta Oncol; 2008; 47(2):207-15. PubMed ID: 18210297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality of life after adjuvant chemotherapy for breast cancer.
    Broeckel JA; Jacobsen PB; Balducci L; Horton J; Lyman GH
    Breast Cancer Res Treat; 2000 Jul; 62(2):141-50. PubMed ID: 11016752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Life quality of women with breast cancer after mastectomy or breast conserving therapy treated with adjuvant chemotherapy.
    Kamińska M; Ciszewski T; Kukiełka-Budny B; Kubiatowski T; Baczewska B; Makara-Studzińska M; Starosławska E; Bojar I
    Ann Agric Environ Med; 2015; 22(4):724-30. PubMed ID: 26706986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvements in health-related quality of life by comprehensive cancer pain therapy: a pilot study with breast cancer outpatients under palliative chemotherapy.
    Puetzler J; Feldmann RE; Brascher AK; Gerhardt A; Benrath J
    Oncol Res Treat; 2014; 37(9):456-62. PubMed ID: 25231685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term quality of life in premenopausal women with node-negative localized breast cancer treated with or without adjuvant chemotherapy.
    Joly F; Espié M; Marty M; Héron JF; Henry-Amar M
    Br J Cancer; 2000 Sep; 83(5):577-82. PubMed ID: 10944595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anxiety and quality of life of women who receive radiation or chemotherapy for breast cancer.
    Schreier AM; Williams SA
    Oncol Nurs Forum; 2004; 31(1):127-30. PubMed ID: 14722597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Offering a choice between two adjuvant chemotherapy regimens: a pilot study to develop a decision aid for women with breast cancer.
    Irwin E; Arnold A; Whelan TJ; Reyno LM; Cranton P
    Patient Educ Couns; 1999 Jul; 37(3):283-91. PubMed ID: 14528554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Impact of Age on Quality of Life in Breast Cancer Patients Receiving Adjuvant Chemotherapy: A Comparative Analysis From the Prospective Multicenter Randomized ADEBAR trial.
    Leinert E; Singer S; Janni W; Harbeck N; Weissenbacher T; Rack B; Augustin D; Wischnik A; Kiechle M; Ettl J; Fink V; Schwentner L; Eichler M
    Clin Breast Cancer; 2017 Apr; 17(2):100-106. PubMed ID: 27884722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring patient- and physician-related factors preventing breast cancer patients from guideline-adherent adjuvant chemotherapy-results from the prospective multi-center study BRENDA II.
    Schwentner L; Van Ewijk R; Kühn T; Flock F; Felberbaum R; Blettner M; Kreienberg R; Janni W; Wöckel A; Singer S
    Support Care Cancer; 2016 Jun; 24(6):2759-66. PubMed ID: 26816089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive function of older patients receiving adjuvant chemotherapy for breast cancer: a pilot prospective longitudinal study.
    Hurria A; Rosen C; Hudis C; Zuckerman E; Panageas KS; Lachs MS; Witmer M; van Gorp WG; Fornier M; D'Andrea G; Moasser M; Dang C; Van Poznak C; Hurria A; Holland J
    J Am Geriatr Soc; 2006 Jun; 54(6):925-31. PubMed ID: 16776787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Palliative care needs of cancer outpatients receiving chemotherapy: an audit of a clinical screening project.
    Morita T; Fujimoto K; Namba M; Sasaki N; Ito T; Yamada C; Ohba A; Hiroyoshi M; Niwa H; Yamada T; Noda T
    Support Care Cancer; 2008 Jan; 16(1):101-7. PubMed ID: 17611783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health-related quality of life in axillary node-negative, estrogen receptor-negative breast cancer patients undergoing AC versus CMF chemotherapy: findings from the National Surgical Adjuvant Breast and Bowel Project B-23.
    Land SR; Kopec JA; Yothers G; Anderson S; Day R; Tang G; Ganz PA; Fisher B; Wolmark N
    Breast Cancer Res Treat; 2004 Jul; 86(2):153-64. PubMed ID: 15319567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality of life and preferences for treatment following systemic adjuvant therapy for early-stage breast cancer.
    Lindley C; Vasa S; Sawyer WT; Winer EP
    J Clin Oncol; 1998 Apr; 16(4):1380-7. PubMed ID: 9552041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychosocial factors and patients' preferences for adjuvant chemotherapy in early breast cancer.
    Duric VM; Butow PN; Sharpe L; Boyle F; Beith J; Wilcken NR; Heritier S; Coates AS; John Simes R; Stockler MR
    Psychooncology; 2007 Jan; 16(1):48-59. PubMed ID: 16856128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of quality of life in women undergoing hormonal therapy for breast cancer: validation of an endocrine symptom subscale for the FACT-B.
    Fallowfield LJ; Leaity SK; Howell A; Benson S; Cella D
    Breast Cancer Res Treat; 1999 May; 55(2):189-99. PubMed ID: 10481946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.